Thermo Fisher Scientific Inc

Indian equity indices tumbled sharply at Monday's open, with the Sensex shedding over 1,650 points, as escalating Middle East tensions and a spike in crude oil above $110 spooked investors.

Thermo Fisher Scientific shares declined 0.98% to $504.82 on Friday, extending a recent downturn. The company has raised $3.8 billion in senior notes to partially fund its acquisition of clinical data firm Clario.

Thermo Fisher Scientific raised $3.8 billion through a multi-tranche bond offering to fund its planned Clario acquisition. Shares closed down nearly 1% on Friday.

Danaher shares fell in extended trading Friday, closing near $212.58. The dip precedes a market holiday, with attention shifting to next week's key inflation report.

Thermo Fisher Scientific shares edged higher Monday after filing a preliminary prospectus for a four-part senior notes offering to fund its planned Clario acquisition. The company reported consolidated debt of $39.38 billion as of December 31, 2025.

Thermo Fisher Scientific closed Friday at $542.83, down 6.7% for the week as investors weigh pressure from academic research funding cuts. The company's 2026 outlook projects adjusted earnings of $24.22 to $24.80 per share.

Thermo Fisher Scientific's stock held near $543 Friday following a sharp decline. The company plans to close a Massachusetts facility by 2026, affecting 80 jobs, while investors await key U.S. economic reports.